Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Continued development of DPX-mRNA formulations is one of the Company's objectives, with BioVaxys pursuing collaborations with ...

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, ...

While the virus has not conclusively been found to spread from person ... Companies including Moderna and Pfizer are working ...

UK Health Security Agency recommend that those who have symptoms of a respiratory illness need to wear a face mask ...

“mRNA technology will complement existing vaccine ... but it’s possible for H5N1 to swap genetic material with a human seasonal flu virus and spawn a new form of influenza with pandemic ...

researchers are making strides toward developing a vaccine for the stomach virus. The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus ...